BIOLINERX
Careers | Contact Us
search

News

Keep up-to-date with BioLineRx's company announcements by visiting the press release archive.

December 11, 2018
January 7, 2019

December 11, 2018
Results of triple combination arm of BL-8040, KEYTRUDA® and chemotherapy expected in H2 2019
November 20, 2018
Designation provides eligibility for 12 years of market exclusivity that complements robust IP estate

Phase 1/2a study ongoing with topline data expected by year-end 2020

October 19, 2018

December 5, 2017

December 11, 2018